Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma

被引：25

作者：

Fayon, Maxime ^{[1
]}

Martinez-Cingolani, Carolina ^{[1
]}

Abecassis, Audrey ^{[1
]}

Roders, Nathalie ^{[1
]}

Nelson, Elisabeth ^{[1
]}

Choisy, Caroline ^{[1
]}

Talbot, Alexis ^{[1
,2
]}

Bensussan, Armand ^{[1
]}

Fermand, Jean-Paul ^{[1
,2
]}

Arnulf, Bertrand ^{[1
,2
]}

Bories, Jean-Christophe ^{[1
]}

机构：

[1] Univ Paris, Inst Rech St Louis, INSERM, UMR 976, Paris, France

[2] St Louis Hosp, Immunohematol, Paris, France

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 04期

关键词：

DARATUMUMAB; DEXAMETHASONE; ANTIBODIES; EXPRESSION; EFFICACY;

D O I：

10.3324/haematol.2019.242453

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1193 / 1197

页数：5

共 12 条

[1] Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics [J].

Bannas, Peter ;

Hambach, Julia ;

Koch-Nolte, Friedrich .

FRONTIERS IN IMMUNOLOGY, 2017, 8

[2] MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors [J].

Brischwein, K ;

Schlereth, B ;

Guller, B ;

Steiger, C ;

Wolf, A ;

Lutterbuese, R ;

Offner, S ;

Locher, M ;

Urbig, T ;

Raum, T ;

Kleindienst, P ;

Wimberger, P ;

Kimmig, R ;

Fichtner, I ;

Kufer, P ;

Hofmeister, R ;

da Silva, AJ ;

Baeuerle, PA .

MOLECULAR IMMUNOLOGY, 2006, 43 (08) :1129-1143

[3] Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell-recruiting Antibody Optimized for Cytotoxicity and Cytokine Release [J].

de Zafra, Christina L. Zuch ;

Fajardo, Flordeliza ;

Zhong, Wendy ;

Bernett, Matthew J. ;

Muchhal, Umesh S. ;

Moore, Gregory L. ;

Stevens, Jennitte ;

Case, Ryan ;

Pearson, Joshua T. ;

Liu, Siyuan ;

McElroy, Patricia L. ;

Canon, Jude ;

Desjarlais, John R. ;

Coxon, Angela ;

Balazs, Mercedesz ;

Nolan-Stevaux, Olivier .

CLINICAL CANCER RESEARCH, 2019, 25 (13) :3921-3933

[4] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma [J].

Dimopoulos, M. A. ;

Oriol, A. ;

Nahi, H. ;

San-Miguel, J. ;

Bahlis, N. J. ;

Usmani, S. Z. ;

Rabin, N. ;

Orlowski, R. Z. ;

Komarnicki, M. ;

Suzuki, K. ;

Plesner, T. ;

Yoon, S. -S. ;

Ben Yehuda, D. ;

Richardson, P. G. ;

Goldschmidt, H. ;

Reece, D. ;

Lisby, S. ;

Khokhar, N. Z. ;

O'Rourke, L. ;

Chiu, C. ;

Qin, X. ;

Guckert, M. ;

Ahmadi, T. ;

Moreau, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14) :1319-1331

[5] A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo (vol 31, pg 1743, 2017) [J].

Hipp, S. ;

Tai, Y-T ;

Blanset, D. ;

Deegen, P. ;

Wahl, J. ;

Thomas, O. ;

Rattel, B. ;

Adam, P. J. ;

Anderson, K. C. ;

Friedrich, M. .

LEUKEMIA, 2017, 31 (10) :2278-2278

[6] Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma [J].

Ise, T. ;

Nagata, S. ;

Kreitman, R. J. ;

Wilson, W. H. ;

Wayne, A. S. ;

Stetler-Stevenson, M. ;

Bishop, M. R. ;

Scheinberg, D. A. ;

Rassenti, L. ;

Kipps, T. J. ;

Kyle, R. A. ;

Jelinek, D. F. ;

Pastan, I. .

LEUKEMIA, 2007, 21 (01) :169-174

[7] Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell Killing [J].

Li, Ji ;

Stagg, Nicola J. ;

Johnston, Jennifer ;

Harris, Michael J. ;

Menzies, Sam A. ;

DiCara, Danielle ;

Clark, Vanessa ;

Hristopoulos, Maria ;

Cook, Ryan ;

Slaga, Dionysos ;

Nakamura, Rin ;

McCarty, Luke ;

Sukumaran, Siddharth ;

Luis, Elizabeth ;

Ye, Zhengmao ;

Wu, Thomas D. ;

Sumiyoshi, Teiko ;

Danilenko, Dimitry ;

Lee, Genee Y. ;

Totpal, Klara ;

Ellerman, Diego ;

Tzel, Isidro Ho ;

James, John R. ;

Junttila, Teemu T. .

CANCER CELL, 2017, 31 (03) :383-395

[8] Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma [J].

Palumbo, Antonio ;

Chanan-Khan, Asher ;

Weisel, Katja ;

Nooka, Ajay K. ;

Masszi, Tamas ;

Beksac, Meral ;

Spicka, Ivan ;

Hungria, Vania ;

Munder, Markus ;

Mateos, Maria V. ;

Mark, Tomer M. ;

Qi, Ming ;

Schecter, Jordan ;

Amin, Himal ;

Qin, Xiang ;

Deraedt, William ;

Ahmadi, Tahamtan ;

Spencer, Andrew ;

Sonneveld, Pieter .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) :754-766

[9] Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival [J].

Sanchez, Eric ;

Li, Mingjie ;

Kitto, Alex ;

Li, Jennifer ;

Wang, Cathy S. ;

Kirk, Dylan T. ;

Yellin, Ori ;

Nichols, Cydney M. ;

Dreyer, Marissa P. ;

Ahles, Cameryn P. ;

Robinson, Austin ;

Madden, Erik ;

Waterman, Gabriel N. ;

Swift, Regina A. ;

Bonavida, Benjamin ;

Boccia, Ralph ;

Vescio, Robert A. ;

Crowley, John ;

Chen, Hai-ming ;

Berenson, James R. .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (06) :727-738

[10] Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment [J].

Seckinger, Anja ;

Antonio Delgado, Jose ;

Moser, Samuel ;

Moreno, Laura ;

Neuber, Brigitte ;

Grab, Anna ;

Lipp, Susanne ;

Merino, Juana ;

Prosper, Felipe ;

Emde, Martina ;

Delon, Camille ;

Latzko, Melanie ;

Gianotti, Reto ;

Luoend, Remo ;

Murr, Ramona ;

Hosse, Ralf J. ;

Harnisch, Lydia Jasmin ;

Bacac, Marina ;

Fauti, Tanja ;

Klein, Christian ;

Zabaleta, Aintzane ;

Hillengass, Jens ;

Cavalcanti-Adam, Elisabetta Ada ;

Ho, Anthony D. ;

Hundemer, Michael ;

San Miguel, Jesus F. ;

Strein, Klaus ;

Umana, Pablo ;

Hose, Dirk ;

Paiva, Bruno ;

Minh Diem Vu .

CANCER CELL, 2017, 31 (03) :396-410

← 1 2 →